Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® H. pylori specialty page provides H. pylori-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


FDA Approves RHB-105 to Treat <i>H Pylori</i>
RHB-105 (Talicia) is the only rifabutin-based therapy approved for the treatment of H pylori infection and is designed to address the high resistance of H pylori bacteria to current clarithromycin-based standard-of-care therapies. 
Antibiotic-Resistant <i>H Pylori</i> is on the Rise in Europe
Helicobacter pylori resistance to clarithromycin more than doubled during the past 20 years, according to new research presented at UEG Week Barcelona 2019.
Gut Bacteria
In a recent study, researchers from several institutions found that individuals from North, Central, and South Americas may be at an increased risk of cancer due to Heliobacter pylori strains brought over to the "New World" with European explorers.
Top 5 <i>Contagion</i>® News Articles for the Month of March 2017
News on Heliobacter pylori, Zika, Clostridium difficile, Powassan virus, and influenza make up the top 5 news articles from Contagion® in March 2017.
Risk Marker for Stomach Cancer Uses Acid Sensors to Control Colonization
In a new study, researchers have discovered that Helicobacter pylori, the presence of which is a risk factor for stomach cancer, uses multiple acid sensors to control colonization of the stomach.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?